cisplatin , 50-150 mg in a maximum concentration of 1 mg/ml , was administered intravesically each week to 24 patients with multiple , recurrent carcinoma in situ and/or bladder tumors confined to the mucosa and lamina propria .
C0008838
cisplatin
C0005695
bladder tumors